Re: Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening.
作者信息
Lehrer Steven, Rheinstein Peter H
机构信息
Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Severn Health Solutions, Severna Park, MD, USA.
出版信息
J Natl Cancer Inst. 2020 Oct 1;112(10):1067-1068. doi: 10.1093/jnci/djaa092.
Abstract
摘要
相似文献
1
Re: Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening.关于：美国预防服务工作组建议不进行筛查后5年的前列腺癌发病率
J Natl Cancer Inst. 2020 Oct 1;112(10):1067-1068. doi: 10.1093/jnci/djaa092.
2
Re: Changes in Prostate-specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening.关于：与美国预防服务工作组修订后的前列腺癌筛查建议相关的前列腺特异性抗原检测变化
Eur Urol. 2022 Mar;81(3):313. doi: 10.1016/j.eururo.2021.12.028. Epub 2022 Jan 10.
3
New US Preventive Service Task Force recommendations for prostate cancer screening: a needed update, but not enough.美国预防服务工作组关于前列腺癌筛查的新建议：虽有必要更新，但仍显不足。
Einstein (Sao Paulo). 2017 Jul-Sep;15(3):7-10. doi: 10.1590/S1679-45082017ED4151.
4
Evolving detection and treatment methods change approaches to prostate cancer: US Preventive Services Task Force draft recommendations now align more closely with others.不断发展的检测和治疗方法改变了前列腺癌的治疗方式：美国预防服务工作组的建议草案现在与其他建议更为一致。
Cancer. 2018 Jan 1;124(1):11-12. doi: 10.1002/cncr.31180.
5
Re: National Prostate Cancer Screening Rates after the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.回复：2012年美国预防服务工作组建议不鼓励基于前列腺特异性抗原的筛查后美国的全国前列腺癌筛查率
J Urol. 2016 Apr;195(4 Pt 1):928-9. doi: 10.1016/j.juro.2016.01.034. Epub 2016 Jan 21.
6
2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.2008年美国预防服务工作组建议与前列腺癌筛查率
JAMA. 2012 Apr 25;307(16):1692-4. doi: 10.1001/jama.2012.534.
7
Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012.2012 年 USPSTF 发布 D 级前列腺特异性抗原筛查建议后，按阶段、NCCN 风险分组和年龄划分的前列腺癌发病率。
Cancer. 2020 Feb 15;126(4):717-724. doi: 10.1002/cncr.32604. Epub 2019 Dec 3.
8
Words of wisdom: Re: Screening for prostate cancer: US Preventive Services Task Force recommendation statement.智慧之言：关于：前列腺癌筛查：美国预防服务工作组建议声明。
Eur Urol. 2013 Sep;64(3):512. doi: 10.1016/j.eururo.2013.06.027.
9
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.美国预防服务工作组“D”级推荐对前列腺癌筛查及分期的影响
Curr Opin Urol. 2017 May;27(3):205-209. doi: 10.1097/MOU.0000000000000383.
10
Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries.2008年美国预防服务工作组建议停止对老年医疗保险男性受益人群进行前列腺癌筛查的影响。
Arch Intern Med. 2012 Nov 12;172(20):1601-3. doi: 10.1001/archinternmed.2012.3726.
引用本文的文献
1
Response to Lehrer and Rheinstein.对莱勒和莱茵斯坦的回应。
J Natl Cancer Inst. 2020 Oct 1;112(10):1069-1070. doi: 10.1093/jnci/djaa093.
本文引用的文献
1
Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening.美国预防服务工作组建议停止前列腺癌筛查 5 年后的发病率。
J Natl Cancer Inst. 2021 Jan 4;113(1):64-71. doi: 10.1093/jnci/djaa068.
2
The 5-year relative survival of older patients with prostate cancer is insignificantly different from the 5-year survival of all men of a similar age.老年前列腺癌患者的5年相对生存率与所有同龄男性的5年生存率相比，差异不显著。
Cancer. 2020 Jun 1;126(11):2718. doi: 10.1002/cncr.32788. Epub 2020 Feb 19.
3
Obesity and aggressive prostate cancer.肥胖与侵袭性前列腺癌。
Cancer. 2020 May 15;126(10):2319. doi: 10.1002/cncr.32761. Epub 2020 Feb 5.
4
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.前列腺癌筛查：美国预防服务工作组推荐声明。
JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710.
5
Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics.国家癌症报告：第二部分：前列腺癌趋势和疾病特征的最新变化。
Cancer. 2018 Jul 1;124(13):2801-2814. doi: 10.1002/cncr.31549. Epub 2018 May 22.
Zotero 插件